Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane

Current Medical Research and Opinion

Volumn 22, Issue 3, 2006, Pages 603-615

  Taylor, Peter W ^a   Keenan, Michael H J ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b Micron Research Ltd   (United Kingdom)

Author keywords

Generic products; Isotretinoin; Pharmaceutical quality; Roaccutane

Indexed keywords

ISOTRETINOIN;

ARTICLE; DEGRADATION; DRUG IMPURITY; DRUG STABILITY; PARTICLE SIZE; SHELF LIFE;

ACNE VULGARIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG PACKAGING; DRUGS, GENERIC; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; PARTICLE SIZE; QUALITY CONTROL; THERAPEUTIC EQUIVALENCY;

EID: 33645213314     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X96326     Document Type: Article

References (22)

1. Jones H, Blanc D, Cunliffe WJ. 13-cis retinoic acid and acne. Lancet 1980;15;2:1048-9
2. Jones DH, King K, Miller AJ, et al. A dose response study of 13-cis retinoic acid in acne vulgaris. Br J Dermatol 1983;108: 333-43
3. Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 1984;10:490-6
4. Haider A, Shaw JC. Treatment of acne vulgaris. J Am Med Assoc 2004;292:726-35
5. Chivot M. Retinoid therapy in acne. A comparative review. Am J Clin Dermatol 2005;6:13-9
6. Tan X, Meltzer N, Lindebaum S. Solid state stability studies of 13-cis-retinoic acid and all-trans-retinoic acid using microcalorimetry and HPLC analysis. Pharm Res 1992;9: 1203-8
7. Ioele G, Cione E, Risoli A, et al. Accelerated photostability study of tretinoin and isotretinoin in liposome formulations. Int. J Pharm 2005;293:251-60
8. Wetterich U, Mutschler E. Arzneimittelforschung. Drug Res 1995;45:74-80
9. Nightingale CH. A survey of the quality of generic clarithromycin products from 13 countries. Clin Drug Invest 2000;19: 293-305
10. Lambert PA, Conway BR. Pharmaceutical quality of ceftriaxone generic drug products compared with Rocephin. J Chemother 2003;15:357-68
11. Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. New Engl J Med 1985;313:837-41
12. Nau H, Chahoud I, Dencker L, et al. Teratogenicity of vitamin A and retinoids. In: Blomhoff R. editor. Vitamin A in health and disease. New York: Marcel Dekker; 1994. p. 615-64
13. Willhite CC, Wier PJ, Berry DL. Dose-response and structure activity considerations in retinoid-induced dysmorphogenesis. Crit Rev Toxicol 1989;20:113-35
14. British Pharmacopoeia Commission. British Pharmacopoeia, 4th ed. [ISBN: 0113225954]. The Stationery Office; 2003
15. European Directorate for the Quality of Medicines (EDQM). European Pharmacopoeia, 4th ed. [ISBN 9287 145873]. The Stationery Office; 2003
16. United States Pharmacopoeia Convention (USPC). United States Pharmacopoeia and the National formulary (USP25, NF20). The Stationery Office; 2002
17. Mannisto P. The effect of crystal size, gastric content and emptying rate on the absorption of nitrofurantoin in healthy human volunteers. Int J Clin Pharmacol Biopharm 1978;16: 223-8
18. Chaumeil JC. Micronization: a method of improving the bioavailability of poorly soluble drugs. Methods Find Exp Clin Pharmacol 1998;20:211-5
19. Berne B, Rollman O, Vahlquist A. UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice. Photodermatol Photoimmunol Photomed 1990;7:146-52
20. Kang K-S, Che J-H, Ryu D-Y, et al. Decreased sperm number and motile activity on the F1 offspring maternally exposed to butyl p-hydroxybenzoic acid (butyl-paraben). J Vet Med Sci 2002;64:227-35
21. Oishi S. Effects of propyl paraben on the male reproductive system. Food Chem Toxicol 2002;40:1807-13
22. Soni MG, Carabin IG, Burdock GA. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem Toxicol 2005;43:985-1015